Showing results (1-10 of 133) with videos related to
Sort By:
Pageof 14
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Diagnostics of pathogenic splicing mutations: does bioinformatics cover all bases?Linda Hartmann, Stephan Theiss, Dieter Niederacher, et al.International Journal of Cancer|December 7, 2007
Invasive breast cancer cells exhibit increased mobility of the actin-binding protein CapGMalte Renz, Beate Betz, Dieter Niederacher, et al.Expert Review of Molecular Diagnostics|November 21, 2015
Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solutionNikolas H Stoecklein, Johannes C Fischer, Dieter Niederacher, et al.Human Mutation|May 18, 2004
Denaturing high-performance liquid chromatography (DHPLC) as a reliable high-throughput prescreening method for aberrant promoter methylation in cancerBeate Betz, Andrea R Florl, Hans-Helge Seifert, et al.International Journal of Molecular Sciences|September 1, 2017
A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM<sup>high</sup> and EpCAM<sup>low/negative</sup> CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast CancerRita Lampignano, Liwen Yang, Martin H D Neumann, et al.BMC Cancer|June 3, 2008
Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancerErik Noetzel, Jürgen Veeck, Dieter Niederacher, et al.Cancer Immunology, Immunotherapy : CII|February 5, 2005
In vivo cervical cancer growth inhibition by genetically engineered cytotoxic T cellsPeter Dall, Isabell Herrmann, Bettina Durst, et al.Reproductive Biology and Endocrinology : RB&E|February 2, 2024
Progesterone-induced progesterone receptor membrane component 1 rise-to-decline changes are essential for decidualizationHailun Liu, André Franken, Alexandra P Bielfeld, et al.Anticancer Research|June 3, 2006
Effects of the antiestrogens tamoxifen and raloxifene on the estrogen receptor transactivation machineryMichael Glaeser, Dieter Niederacher, Sirus Djahansouzi, et al.Journal of Cancer Research and Clinical Oncology|June 10, 2010
Expression of the Wnt antagonist DKK3 is frequently suppressed in sporadic epithelial ovarian cancerAn You, Emmanouil Fokas, Lin-Fang Wang, et al.Pageof 14